Sheets Smith Wealth Management
Source: SEC Form 13F · as of Mar 2026Sheets Smith Wealth Management holds 21 biotech & pharma companies tracked by BioSniper, totaling $51.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$51.5M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 14,414 | $13.3M |
| IQVIQVIA Holdings Inc. | 38,194 | $6.5M |
| AMGNAMGEN INC | 17,693 | $6.2M |
| CORCencora Inc. | 14,439 | $4.5M |
| IBRXImmunityBio, Inc. | 552,025 | $4.2M |
| ABBVAbbVie Inc. | 14,875 | $3.2M |
| JNJJOHNSON & JOHNSON | 10,709 | $2.6M |
| MRKMerck & Co., Inc. | 21,382 | $2.6M |
| MEDPMedpace Holdings Inc. | 3,035 | $1.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 5,011 | $1.4M |
| GILDGILEAD SCIENCES, INC. | 7,246 | $1.0M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,299 | $1.0M |
| CAHCardinal Health Inc. | 3,907 | $826K |
| PFEPFIZER INC | 14,531 | $408K |
| NVSNovartis AG | 2,450 | $374K |
| AVXLANAVEX LIFE SCIENCES CORP. | 117,805 | $362K |
| ABTABBOTT LABORATORIES | 3,260 | $335K |
| BMYBRISTOL MYERS SQUIBB CO | 5,132 | $311K |
| ZTSZoetis Inc. | 2,381 | $281K |
| IDXXIDEXX LABORATORIES INC /DE | 486 | $273K |
| PMPhilip Morris International Inc | 1,628 | $269K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.